Article Listing - Russia's ChemRar gets rights to Pfizer's DPP-IVi diabetes candidate

CHOLINE KEY TO ALZHEIMER'S?

9 March 1992

New research has indicated that a deficiency of the acetylcholine precursor choline may be a prime factor in the etiology...

CORTICOSTEROIDS AND OPTIC NEURITIS

9 March 1992

Optic neuritis, an acute demyelinating disease of the optic nerve which often occurs in multiple sclerosis patients, can be successfully...

ANTI-LEPTOSPIRA MAbs FROM BRAZIL

9 March 1992

Researchers at the Oswaldo Cruz Foundation in Rio de Janeiro, Brazil, claim to have produced monoclonal antibodies specific for blood-borne...

ROCHE CENTER ESTABLISHED IN USA

9 March 1992

A new study center for nervous system injuries at Washington University in St Louis, Missouri, is being set up to...

CHANGING FACE OF THE ASTHMA MARKET

9 March 1992

While some analysts have voiced belief that Glaxo may have a tough time getting its long-acting bronchodilator Serevent (salmeterol xinafoate)...

ROCHE TO PROMOTE GENENTECH'S DNase

9 March 1992

Swiss major Hoffmann-La Roche and Californian biotechnology concern Genentech last week announced four different international R&D agreements using their combined...

US GAO SLAMS FDA REVIEW OF OTCs

9 March 1992

There is less US Food and Drug Administration scrutiny of over-the-counter drug products than of prescription products, says a new...

PRODUCT UPDATE FROM INTERNEURON PHARMA

9 March 1992

Massachusetts company Interneuron Pharma has signed an agreement with Purdue University to license exclusive worldwide rights to its putative antiparkinsonism...

BAYER AG'S JONATHAN TALBUTT

9 March 1992

Jonathan Talbutt is appointed international product manager, diabetes, at Bayer AG, based in Leverkusen, Germany.

NONABSORBABLE ANTIBIOTICS

9 March 1992

Decontamination of the digestive tract with topical nonabsorbable antibiotics does not improve survival among patients receiving mechanical ventilation in the...

Showing 94731-94740 of 95341 articles